TOP 2016
RESEARCH
ASCO 2016
•
•
10 years of AI for breast cancer
•
•
Daratumumab combo for MM
•
•
Adjuvant temozolomide
in glioma
•
•
Checkpoint inhibitors in
refractory cancers
EHA 2016
•
•
Novel gene variants in
bleeding, platelet disorders
•
•
IDH-1/2 mutation in AML
•
•
Inotuzumab ozogamicin in ALL
ESMO 2016
•
•
Cabozantinib in RCC
•
•
Ribociclib + letrozole
paradigm shift
•
•
Pembrolizumab in
prostate cancer
HAA 2016
•
•
Daratumumab in MM
•
•
Venetoclax in elderly AML
•
•
Pregnant women and
low platelets
•
•
Hydroxyurea for sickle
cell disease
Best of 2016
DECEMBER 2016
RESEARCH NEWS AND VIEWS FROM ELSEVIER